For example, the GSTM1 deletion and multiple NAT (N-acetyltransferase) variants were often considered together as the leading candidates for explaining the genetic basis of bladder cancer susceptibility (García-Closas et al. 2005). This evidence concerns the gene BRD2 and urinary bladder carcinoma.